Home › Cancro pancreatico › Florida › Tampa
Studi clinici su Cancro pancreatico a Tampa, FL
26 studi su Cancro pancreatico cercano partecipanti presso sedi a Tampa e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
In reclutamentoFase 3
- Moffitt Cancer Center, Tampa
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
In reclutamentoFase 1
- Moffitt Cancer Center, Tampa
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
In reclutamentoStudio osservazionale
- Moffitt Cancer Center, Tampa
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
In reclutamentoFase 1/2
- Moffitt Cancer Center, Tampa
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
In reclutamentoFase 1/2
- Moffitt Cancer Center and Research Institute, Tampa
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
In reclutamentoFase 1/2
- Moffitt Cancer Center, Tampa
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer
In reclutamento
- Moffitt Cancer Center, Tampa
Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
In reclutamentoFase 3
- Moffitt Cancer Center, Tampa
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
In reclutamentoFase 2
- Moffitt Cancer Center, Tampa
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
In reclutamentoFase 3
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens
In reclutamento
- Moffitt Cancer Center, Tampa
Pancreatic Cancer Early Detection Consortium
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Moffitt Cancer Center, Tampa
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
In reclutamentoFase 1
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
In reclutamentoFase 1/2
- Moffitt Cancer Center, Tampa
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
In reclutamentoFase 1
- Moffitt Cancer Center, Tampa
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
In reclutamentoFase 1
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Tampa
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
In reclutamentoFase 1
- Lee Moffitt Cancer Center, Tampa
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
In reclutamentoFase 1/2
- Moffitt Cancer Center, Tampa
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
In reclutamentoFase 3
- Moffitt Cancer Center - McKinley Campus, Tampa
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
In reclutamentoFase 2
- Ohio State University-Telemedicine, Tampa
A First-in-Human Study of FID-022 in Solid Tumor Patients
In reclutamentoStudio osservazionale
- Moffitt Cancer Center, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Tampa
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- Exelixis Clinical Site #16, Tampa
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
In reclutamentoFase 1
- H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa
Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
In reclutamentoFase 1/2
- Tampa General Hospital, Tampa
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
In reclutamentoStudio osservazionale
- University of South Florida, Tampa
Studi su Cancro pancreatico in altre città
- Houston, TX61 studi
- New York City, NY60 studi
- Boston, MA43 studi
- Nashville, TN39 studi
- Los Angeles, CA35 studi
- St. Louis, MO33 studi
- Arlington, VA33 studi
- Baltimore, MD31 studi
- San Antonio, TX31 studi
- Philadelphia, PA26 studi
- Durham, NC24 studi
- San Diego, CA24 studi
Altri studi a Tampa
- Cancro del polmone non a piccole cellule51 studi
- Cancro al seno43 studi
- Cancro (tutti i tipi)39 studi
- Cancro colorettale34 studi
- Leucemia mieloide acuta29 studi
- Cancro metastatico29 studi
- Cancro ai polmoni29 studi
- Cancro ovarico21 studi
- Melanoma19 studi
- Sindromi mielodisplastiche19 studi
- Cancro alla prostata18 studi
- Insufficienza cardiaca18 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.